12-[2-(Benzyl-methyl-amino)-ethyl]-2,3-dimethoxy-12H-8,10-dioxa-6,12-diaza-cyclopenta[b]chrysen-13-one

ID: ALA370251

PubChem CID: 11179500

Max Phase: Preclinical

Molecular Formula: C29H27N3O5

Molecular Weight: 497.55

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc2c(=O)n(CCN(C)Cc3ccccc3)c3c4cc5c(cc4ncc3c2cc1OC)OCO5

Standard InChI:  InChI=1S/C29H27N3O5/c1-31(16-18-7-5-4-6-8-18)9-10-32-28-21-13-26-27(37-17-36-26)14-23(21)30-15-22(28)19-11-24(34-2)25(35-3)12-20(19)29(32)33/h4-8,11-15H,9-10,16-17H2,1-3H3

Standard InChI Key:  VSRFWSKODMQGLJ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 37 42  0  0  0  0  0  0  0  0999 V2000
   -0.2708    0.0833    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2708    0.9083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9833   -0.3292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9833    1.3208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7000    0.9083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7000    0.0833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4417    1.3208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4417    2.1500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1542    0.9083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4125    1.3208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4125   -0.3292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2750    2.5625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9833    2.1500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1542    2.5625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4542   -0.3375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8792    1.3208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8792    2.1500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1333    0.9083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1333    0.0833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9833   -1.1542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6542    1.0708    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6542    2.4083    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1417    1.7458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1542   -1.5792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4417   -1.1625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1542   -2.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8458    1.3375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8458   -0.3375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8667   -2.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8667   -1.1625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5708    0.9208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5708    0.0708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5875   -2.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8667   -3.6542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3042   -2.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5792   -4.0625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3042   -3.6542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  2  2  0
  5  6  1  0
  6  3  1  0
  7  2  1  0
  8  7  2  0
  9  7  1  0
 10  5  2  0
 11  6  2  0
 12  8  1  0
 13  4  1  0
 14  8  1  0
 15  1  1  0
 16  9  2  0
 17 16  1  0
 18 19  2  0
 19 11  1  0
 20  3  2  0
 21 16  1  0
 22 17  1  0
 23 21  1  0
 24 25  1  0
 25 15  1  0
 26 24  1  0
 27 18  1  0
 28 19  1  0
 29 26  1  0
 30 24  1  0
 31 27  1  0
 32 28  1  0
 33 29  1  0
 34 29  2  0
 35 33  2  0
 36 34  1  0
 37 36  2  0
  5  4  1  0
 12 13  2  0
 18 10  1  0
 17 14  2  0
 23 22  1  0
 37 35  1  0
M  END

Associated Targets(Human)

RPMI 8402 (281 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KB 3-1 (1143 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TOP1 Tclin DNA topoisomerase I (7553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

P388 (20296 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 497.55Molecular Weight (Monoisotopic): 497.1951AlogP: 4.58#Rotatable Bonds: 7
Polar Surface Area: 75.05Molecular Species: NEUTRALHBA: 8HBD:
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.07CX LogP: 3.81CX LogD: 3.06
Aromatic Rings: 5Heavy Atoms: 37QED Weighted: 0.30Np Likeness Score: -0.68

References

1. Ruchelman AL, Houghton PJ, Zhou N, Liu A, Liu LF, LaVoie EJ..  (2005)  5-(2-aminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones: variation of n-alkyl substituents modulates sensitivity to efflux transporters associated with multidrug resistance.,  48  (3): [PMID:15689163] [10.1021/jm049447z]
2. Zhou W, Dai Z, Chen Y, Yuan Z.  (2013)  Computational QSAR models with high-dimensional descriptor selection improve antitumor activity design of ARC-111 analogues,  22  (1): [10.1007/s00044-012-0034-x]

Source